PWM
MEDP icon

Parkworth Wealth Management’s Medpace MEDP Stock Holding History

Parkworth Wealth Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$314 Hold
1
– – ﹤0.01% 777
2025
Q1 		$305 Hold
1
– – ﹤0.01% 587
2024
Q4 		$332 Buy
+1
New +$339 ﹤0.01% 569

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Parkworth Wealth Management's MEDP Position: Q2 2025 in Review

Parkworth Wealth Management held its Medpace (MEDP) position steady in Q2 2025 at 1 share worth $314. The position accounts for ﹤0.01% of the portfolio, ranked #777.

Parkworth Wealth Management first reported a position in MEDP in Q4 2024 and has held it in 3 quarters since. The position peaked at $332 in Q4 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • Parkworth Wealth Management held 1 share of Medpace worth $314 as of Q2 2025.
  • Parkworth Wealth Management left its Medpace share count unchanged in Q2 2025.
  • Medpace made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #777 holding.
  • Parkworth Wealth Management first reported a position in Medpace in Q4 2024 and has held it in 3 quarters since.
  • Parkworth Wealth Management's Medpace position peaked at $332 in Q4 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.